141 related articles for article (PubMed ID: 25572804)
21. The sweet approach is still worthwhile in modern esophagectomy.
Ma J; Zhan C; Wang L; Jiang W; Zhang Y; Shi Y; Wang Q
Ann Thorac Surg; 2014 May; 97(5):1728-33. PubMed ID: 24650587
[TBL] [Abstract][Full Text] [Related]
22. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy.
Nakagawa S; Kanda T; Kosugi S; Ohashi M; Suzuki T; Hatakeyama K
J Am Coll Surg; 2004 Feb; 198(2):205-11. PubMed ID: 14759776
[TBL] [Abstract][Full Text] [Related]
23. Survival risk prediction model for patients with pT
Qi Z; Hu Y; Qiu R; Li J; Li Y; He M; Wang Y
J Cardiothorac Surg; 2021 May; 16(1):121. PubMed ID: 33933129
[TBL] [Abstract][Full Text] [Related]
24. Indications for three-field dissection followed by esophagectomy for advanced carcinoma of the thoracic esophagus.
Tabira Y; Okuma T; Kondo K; Kitamura N
J Thorac Cardiovasc Surg; 1999 Feb; 117(2):239-45. PubMed ID: 9918963
[TBL] [Abstract][Full Text] [Related]
25. [Comparative analysis on the classic and modified Ivor-Lewis procedure in the treatment of mid-low thoracic esophageal carcinoma].
Zhen FX; Luo JH; Zhang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Dec; 16(12):1180-2. PubMed ID: 24369401
[TBL] [Abstract][Full Text] [Related]
26. A prospective trial for avoiding cervical lymph node dissection for thoracic esophageal cancers, based on intra-operative genetic diagnosis of micrometastasis in recurrent laryngeal nerve chain nodes.
Miyata H; Yano M; Doki Y; Yasuda T; Yoshioka S; Sugita Y; Takiguchi S; Fujiwara Y; Monden M
J Surg Oncol; 2006 May; 93(6):477-84. PubMed ID: 16615150
[TBL] [Abstract][Full Text] [Related]
27. Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?
Yu E; Dar R; Rodrigues GB; Stitt L; Videtic GM; Truong P; Tomiak A; Ash R; Brecevic E; Inculet R; Malthaner R; Vincent M; Craig I; Kocha W; Lefcoe M
Radiother Oncol; 2004 Nov; 73(2):141-8. PubMed ID: 15542160
[TBL] [Abstract][Full Text] [Related]
28. Clinical outcomes and prognosis after thoracoscopic esophagectomy with two-field lymph node dissection for lower thoracic esophageal cancer.
Takemura M; Hori T; Fujiwara Y
Anticancer Res; 2013 Feb; 33(2):601-8. PubMed ID: 23393354
[TBL] [Abstract][Full Text] [Related]
29. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.
Tapias LF; Mathisen DJ; Wright CD; Wain JC; Gaissert HA; Muniappan A; Lanuti M; Donahue DM; Morse CR
Ann Thorac Surg; 2016 Mar; 101(3):1097-103. PubMed ID: 26652140
[TBL] [Abstract][Full Text] [Related]
30. Caveolin-1 in multi drug resistance and two-field lymphadenectomy for thoracic esophageal squamous cell carcinoma.
Fang W; Ruan W; Lin S; Chen Y; Zhu K
Pak J Pharm Sci; 2017 Sep; 30(5(Special)):1857-1866. PubMed ID: 29084658
[TBL] [Abstract][Full Text] [Related]
31. Postoperative radiotherapy for the young-old patients with thoracic esophageal squamous cell carcinoma: A 2-center experience.
Ding W; Yang M; Jiang W; Ge X; Sun X; Zhou B; Liu F; Jiang K; Shen F; Sun X
Medicine (Baltimore); 2020 Apr; 99(17):e19453. PubMed ID: 32332598
[TBL] [Abstract][Full Text] [Related]
32. Intraoperative radiation therapy to the upper mediastinum and nerve-sparing three-field lymphadenectomy followed by external beam radiotherapy for patients with thoracic esophageal carcinoma.
Hosokawa M; Shirato H; Ohara M; Kagei K; Hashimoto S; Nishino S; Takamura A; Arimoto T
Cancer; 1999 Jul; 86(1):6-13. PubMed ID: 10391557
[TBL] [Abstract][Full Text] [Related]
33. [The patterns and prognostic factors of abdominal lymph node metastasis in patients with the middle thoracic esophageal squamous cell carcinoma].
Wang Z; Liu XY; Liu FY
Zhonghua Wai Ke Za Zhi; 2008 Dec; 46(23):1800-3. PubMed ID: 19094790
[TBL] [Abstract][Full Text] [Related]
34. Can common hepatic artery lymph node dissection be safely omitted in surgery for clinical T1N0 thoracic esophageal squamous cell carcinoma?
Shim YM; Park JS; Lee M; Kim D; Kim K
Dis Esophagus; 2013 Apr; 26(3):272-5. PubMed ID: 22642487
[TBL] [Abstract][Full Text] [Related]
35. Ivor Lewis approach is superior to transhiatal approach in retrieval of lymph nodes at esophagectomy.
Wolff CS; Castillo SF; Larson DR; O'Byrne MM; Fredericksen M; Deschamps C; Allen MS; Zais TG; Romero Y
Dis Esophagus; 2008; 21(4):328-33. PubMed ID: 18477255
[TBL] [Abstract][Full Text] [Related]
36. Initial experience of total thoracoscopic and laparoscopic Ivor Lewis esophagectomy.
Merritt RE
J Laparoendosc Adv Surg Tech A; 2012 Apr; 22(3):214-9. PubMed ID: 22393924
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
[TBL] [Abstract][Full Text] [Related]
38. Ivor Lewis subtotal esophagectomy with two-field lymphadenectomy for squamous cell carcinoma of the lower thoracic esophagus.
Wu J; Chai Y; Zhou XM; Chen QX; Yan FL
World J Gastroenterol; 2008 Aug; 14(32):5084-9. PubMed ID: 18763294
[TBL] [Abstract][Full Text] [Related]
39. [Feasibility and safety of radical mediastinal lymphadenectomy in thoracoscopic esophagectomy for esophageal cancer].
Zhang Y; Tan LJ; Feng MX; Wang H; Wang Q
Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):855-9. PubMed ID: 23291137
[TBL] [Abstract][Full Text] [Related]
40. Postoperative Radiotherapy Improves Survival in Stage pT2N0M0 Esophageal Squamous Cell Carcinoma with High Risk of Poor Prognosis.
Wang S; Wang Z; Yang Z; Liu Y; Liu X; Shang B; Jiang WP
Ann Surg Oncol; 2016 Jan; 23(1):265-72. PubMed ID: 26014154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
